01 1TOPHARMAN SHANDONG CO LTD
01 1TADALAFIL
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2021-08-25
Pay. Date : 2021-06-28
DMF Number : 33012
Submission : 2018-08-10
Status : Active
Type : II
20
Topharman Shandong Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is TADALAFIL, with a corresponding US DMF Number 33012.
Remarkably, this DMF maintains an Active status since its submission on August 10, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 25, 2021, and payment made on June 28, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II
